NumerixS Investment Technologies’s Dr. Reddy's Laboratories RDY Stock Holding History

NumerixS Investment Technologies’s Portfolio RDY Stock Details RDY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-3,500	Closed	-$37K	–	661
2020 Q2	$37K	Sell	3,500 -1,500	-30%	-$15.3K	0.01%	855
2020 Q1	$40K	Sell	5,000 -2,000	-29%	-$16.7K	0.02%	663
2019 Q4	$57K	Sell	7,000 -4,000	-36%	-$31.6K	0.01%	790
2019 Q3	$83K	Hold	11,000	–	–	0.02%	605
2019 Q2	$82K	Buy	11,000 +6,000	+120%	+$47.2K	0.02%	653
2019 Q1	$40K	Buy	5,000 +3,000	+150%	+$22.8K	0.01%	1019
2018 Q4	$15K	Buy	2,000 +500	+33%	+$3.52K	﹤0.01%	958
2018 Q3	$10K	Sell	1,500 -20,000	-93%	-$134K	﹤0.01%	1135
2018 Q2	$140K	Buy	21,500 +11,500	+115%	+$72.5K	0.03%	638
2018 Q1	$66K	Buy	+10,000	New	+$70.1K	0.02%	758
2017 Q4	–	Sell	-22,500	Closed	-$161K	–	1320
2017 Q3	$161K	Buy	22,500 +16,000	+246%	+$115K	0.04%	576
2017 Q2	$55K	Sell	6,500 -32,500	-83%	-$264K	0.01%	942
2017 Q1	$313K	Hold	39,000	–	–	0.04%	569
2016 Q4	$353K	Buy	+39,000	New	+$363K	0.04%	498

Other funds holding RDY

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Aperio Group Sausalito, California $33.8B AUM 31.46% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return

NumerixS Investment Technologies's RDY Position: Q3 2020 in Review

NumerixS Investment Technologies sold out of Dr. Reddy's Laboratories (RDY) in Q3 2020, closing a stake of 3,500 shares — an estimated $37K sold.

NumerixS Investment Technologies first reported a position in RDY in Q4 2016 and held it in 14 quarters. The position peaked at $353K in Q4 2016. 186 funds tracked by Wall St. Rank hold RDY as of Q3 2020.

NumerixS Investment Technologies reported no remaining Dr. Reddy's Laboratories position as of Q3 2020 after selling out during the quarter.
NumerixS Investment Technologies sold 3,500 Dr. Reddy's Laboratories shares in Q3 2020, an estimated $37K.
NumerixS Investment Technologies first reported a position in Dr. Reddy's Laboratories in Q4 2016 and held it in 14 quarters.
NumerixS Investment Technologies's Dr. Reddy's Laboratories position peaked at $353K in Q4 2016.
186 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q3 2020.

Based on NumerixS Investment Technologies's 13F filing for Q3 2020.